ten malignant hyperthermia-susceptible ( mhs ) patients were given a total dose of 5 mg.kg-1 of oral dantrolene in three or four divided doses , every 6 h , with the last dose 4 h preoperatively .
C0024591
malignant hyperthermia
C0010976
dantrolene